Seres Therapeutics
MCRB
MCRB
72 hedge funds and large institutions have $243M invested in Seres Therapeutics in 2018 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 27 increasing their positions, 15 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
72
Holders Change
-6
Holders Change %
-7.69%
% of All Funds
1.65%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
27
Reduced
15
Closed
10
Calls
$165K
Puts
$93K
Net Calls
+$72K
Net Calls Change
-$192K
Top Buyers
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
$30.7M |
| 2 |
BlackRock
New York
|
$17.3M |
| 3 |
JPMorgan Chase & Co
New York
|
$3.2M |
| 4 |
State Street
Boston,
Massachusetts
|
$2.97M |
| 5 |
Renaissance Technologies
New York
|
$5.74M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
76
Squarepoint
New York
| – | -$118K | -684 | Closed |
|
|
SWM
77
SeaCrest Wealth Management
Purchase,
New York
| – | -$9K | -50 | Closed |
|
|
RWP
78
RWA Wealth Partners
Newton,
Massachusetts
| – | -$9K | -50 | Closed |
|
|
SPIA
79
Steward Partners Investment Advisory
New York
| – | -$3K | -20 | Closed |
|
|
PIA
80
Piedmont Investment Advisors
Durham,
North Carolina
| – | -$3K | -18 | Closed |
|